TCL Archive Managed Care Plans Seek Cost Efficacy, Not Research, Center Directors Warned March 17, 1995
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983